KOA SHOJI HOLDINGS CO.,LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 816 JPY | -1.92% |
|
-4.11% | +11.48% |
| Sales 2024 * | 22.9B 148M | Sales 2025 * | 24.3B 157M | Capitalization | 32.33B 209M |
|---|---|---|---|---|---|
| Net income 2024 * | 2.91B 18.82M | Net income 2025 * | 3.3B 21.35M | EV / Sales 2024 * | 1 x |
| Net cash position 2024 * | 9.42B 60.91M | Net cash position 2025 * | 10.34B 66.9M | EV / Sales 2025 * | 0.9 x |
| P/E ratio 2024 * |
11.1
x | P/E ratio 2025 * |
9.8
x | Employees | 297 |
| Yield 2024 * |
1.59% | Yield 2025 * |
1.72% | Free-Float | 26.7% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.92% | ||
| 1 week | -4.11% | ||
| Current month | -7.59% | ||
| 1 month | -0.12% | ||
| 3 months | +12.71% | ||
| 6 months | +13.81% | ||
| Current year | +11.48% |
1 week
811.00
864.00
1 month
810.00891.00
Current year
699.00891.00
1 year
639.00891.00
3 years
563.00945.00
5 years
182.50945.00
10 years
175.75945.00
| Managers | Title | Age | Since |
|---|---|---|---|
Miyoko Komatsu
DFI | Director of Finance/CFO | 59 | 15-06-30 |
Toshiyuki Shuto
PSD | President | 77 | 15-01-29 |
Teruyuki Tanaka
BRD | Director/Board Member | 74 | 17-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Taigi Ito
BRD | Director/Board Member | 77 | 18-08-31 |
Toshiyuki Shuto
PSD | President | 77 | 15-01-29 |
Ritsuko Otsuka
BRD | Director/Board Member | 46 | 15-01-29 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.03% | 32 M€ | +25.27% | ||
| 0.00% | 18 M€ | +16.15% | - | |
| 0.00% | 20,721 M€ | +11.13% | - | |
| 0.00% | 144,586 M€ | +12.12% | ||
| 0.00% | 66,066 M€ | +12.28% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 816 | -1.92% | 67 000 |
| 24-04-18 | 832 | +0.60% | 32,700 |
| 24-04-17 | 827 | -1.43% | 33,700 |
| 24-04-16 | 839 | -1.87% | 36,800 |
| 24-04-15 | 855 | +1.18% | 35,700 |
Delayed Quote Japan Exchange, April 19, 2024 at 02:00 am EDT
More quotes
KOA SHOJI HOLDINGS CO., LTD. is engaged in purchasing and sales of drug substance, manufacturing, purchasing and sales of pharmaceuticals, including medical prescription drugs and general pharmaceutical products, as well as contract manufacturing of formulation of pharmaceuticals. The Company operates through two business segments. The pharmaceutical manufacturing and sales business is engaged in development, manufacturing, contract manufacturing and sales of generic injection, oral preparation and external preparation. The drug substance sales business is engaged in import and export of generic drug raw materials, as well as introducing and supply of pharmaceutical raw materials and preparations.
Sector
Commodity Chemicals
Calendar
2024-05-09
- Q3 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
832
JPY
Average target price
1,500
JPY
Spread / Average Target
+80.29%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +11.48% | 213M | |
| -25.90% | 1.62B | |
| -1.11% | 1.13B | |
| -8.12% | 906M | |
| -14.22% | 587M | |
| +12.92% | 519M | |
| +24.35% | 500M | |
| +16.75% | 286M | |
| -24.51% | 249M | |
| -2.74% | 189M |
- Stock Market
- Equities
- 9273 Stock
